These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9180623)

  • 1. Safety and feasibility of dobutamine-atropine stress testing in hypertensive patients.
    Elhendy A; van Domburg RT; Roelandt JR; Geleijnse ML; Ibrahim MM; Fioretti PM
    Hypertension; 1997 Jun; 29(6):1232-9. PubMed ID: 9180623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test.
    Elhendy A; van Domburg RT; Poldermans D; Bax JJ; Nierop PR; Geleijnse ML; Roelandt JR
    Diabetes Care; 1998 Nov; 21(11):1797-802. PubMed ID: 9802723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, hemodynamic profile, and feasibility of dobutamine stress technetium myocardial perfusion single-photon emission CT imaging for evaluation of coronary artery disease in the elderly.
    Elhendy A; van Domburg RT; Bax JJ; Valkema R; Reijs AE; Krenning EP; Roelandt JR
    Chest; 2000 Mar; 117(3):649-56. PubMed ID: 10712987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of dobutamine-atropine stress myocardial perfusion scintigraphy.
    Elhendy A; Valkema R; van Domburg RT; Bax JJ; Nierop PR; Cornel JH; Geleijnse ML; Reijs AE; Krenning EP; Roelandt JR
    J Nucl Med; 1998 Oct; 39(10):1662-6. PubMed ID: 9776264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dobutamine-atropine stress echocardiography and clinical data for predicting late cardiac events in patients with suspected coronary artery disease.
    Poldermans D; Fioretti PM; Boersma E; Cornel JH; Borst F; Vermeulen EG; Arnese M; el-Hendy A; Roelandt JR
    Am J Med; 1994 Aug; 97(2):119-25. PubMed ID: 8059777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease.
    Poldermans D; Fioretti PM; Boersma E; Forster T; van Urk H; Cornel JH; Arnese M; Roelandt RT
    Am J Cardiol; 1994 Mar; 73(7):456-9. PubMed ID: 8141086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The side effects and safety of the echo-dobutamine test. The experience with 373 patients].
    Fetiveau R; Lanzarini L; Poli A; Diotallevi P; Mussini MF; Montemartini C; Previtali M
    G Ital Cardiol; 1995 Feb; 25(2):193-201. PubMed ID: 7642024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Experience in 1118 patients.
    Mertes H; Sawada SG; Ryan T; Segar DS; Kovacs R; Foltz J; Feigenbaum H
    Circulation; 1993 Jul; 88(1):15-9. PubMed ID: 8319327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonexercise stress transthoracic echocardiography: transesophageal atrial pacing versus dobutamine stress.
    Lee CY; Pellikka PA; McCully RB; Mahoney DW; Seward JB
    J Am Coll Cardiol; 1999 Feb; 33(2):506-11. PubMed ID: 9973032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atropine increases the accuracy of dobutamine stress echocardiography in patients taking beta-blockers.
    Fioretti PM; Poldermans D; Salustri A; Forster T; Bellotti P; Boersma E; McNeill AJ; el-Said ES; Roelandt JR
    Eur Heart J; 1994 Mar; 15(3):355-60. PubMed ID: 8013509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of dobutamine echocardiography protocols and indications: safety and side effects in 3,011 studies over 5 years.
    Secknus MA; Marwick TH
    J Am Coll Cardiol; 1997 May; 29(6):1234-40. PubMed ID: 9137218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dobutamine-atropine stress echocardiography in elderly patients unable to perform an exercise test. Hemodynamic characteristics, safety, and prognostic value.
    Poldermans D; Fioretti PM; Boersma E; Thomson IR; Cornel JH; ten Cate FJ; Arnese M; van Urk H; Roelandt JR
    Arch Intern Med; 1994 Dec 12-26; 154(23):2681-6. PubMed ID: 7993151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and predictors of complications with a new accelerated dobutamine stress echocardiography protocol.
    San Román JA; Sanz-Ruiz R; Ortega JR; Pérez-Paredes M; Rollán MJ; Muñoz AC; Segura F; Jimenez D; Carnero A; Pinedo M; Arnold R; Gómez I; Fernández-Aviles F
    J Am Soc Echocardiogr; 2008 Jan; 21(1):53-7. PubMed ID: 17628422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dobutamine-induced hypoperfusion without transient wall motion abnormalities: less severe ischemia or less severe stress?
    Elhendy A; Geleijnse ML; Roelandt JR; van Domburg RT; TenCate FJ; Cornel JH; Reijs AE; el-Said GM; Fioretti PM
    J Am Coll Cardiol; 1996 Feb; 27(2):323-9. PubMed ID: 8557901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Feasibility and safety of dobutamine stress echocardiography: experiences with 1,000 studies].
    Zahn R; Lotter R; Nohl H; Schiele R; Bergmeier C; Zander M; Seidl K; Senges J
    Z Kardiol; 1996 Jan; 85(1):28-34. PubMed ID: 8717145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antianginal therapy with a calcium antagonist and nitrates on dobutamine-atropine stress echocardiography. Comparison with exercise electrocardiography.
    Dodi C; Pingitore A; Sicari R; Bruno G; Cordovil A; Picano E
    Eur Heart J; 1997 Feb; 18(2):242-7. PubMed ID: 9043840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and utility of atropine addition during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction.
    Poldermans D; Rambaldi R; Bax JJ; Cornel JH; Thomson IR; Valkema R; Boersma E; Fioretti PM; Breburda CS; Roelandt JR
    Eur Heart J; 1998 Nov; 19(11):1712-8. PubMed ID: 9857925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of resting wall motion abnormalities in 2-dimensional echocardiography in patients without previous myocardial infarction referred for pharmacologic stress testing.
    Elhendy A; van Domburg RT; Bax JJ; Roelandt JR
    J Am Soc Echocardiogr; 2000 Jan; 13(1):1-8. PubMed ID: 10625825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired systolic blood pressure response to dobutamine stress testing: a marker of more severe functional abnormalities in patients with myocardial infarction.
    Elhendy A; van Domburg RT; Nierop PR; Geleijnse ML; Bax JJ; Kasprzak JD; Liqui-Lung AF; Ibrahim MM; Roelandt JR
    J Am Soc Echocardiogr; 1998 May; 11(5):436-41. PubMed ID: 9619615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of stress/rest myocardial perfusion tomography, dipyridamole and dobutamine stress echocardiography for the detection of coronary disease in hypertensive patients with chest pain and positive exercise test.
    Fragasso G; Lu C; Dabrowski P; Pagnotta P; Sheiban I; Chierchia SL
    J Am Coll Cardiol; 1999 Aug; 34(2):441-7. PubMed ID: 10440157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.